Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function
MG Sturgill, GH Lambert - Clinical chemistry, 1997 - academic.oup.com
Xenobiotic-induced liver injury is a clinically important etiology of hepatic disease that, if not
recognized, can lead to hepatic failure. In this article we discuss the mechanisms of …
recognized, can lead to hepatic failure. In this article we discuss the mechanisms of …
Drug glucuronidation in humans
JO Miners, PI Mackenzie - Pharmacology & therapeutics, 1991 - Elsevier
Glucuronidation is a major metabolic pathway for a large number of drugs in humans.
Conjugation of drugs and other chemicals with glucuronic acid is catalyzed by the multigene …
Conjugation of drugs and other chemicals with glucuronic acid is catalyzed by the multigene …
Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of …
MA Butler, M Iwasaki, FP Guengerich… - Proceedings of the …, 1989 - National Acad Sciences
Aromatic amines are well known as occupational carcinogens and are found in cooked
foods, tobacco smoke, synthetic fuels, and agricultural chemicals. For the primary …
foods, tobacco smoke, synthetic fuels, and agricultural chemicals. For the primary …
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
MA Butler, NP Lang, JF Young… - Pharmacogenetics …, 1992 - journals.lww.com
The wide variations in urinary bladder and colo-rectal cancer incidence in humans have
been attributed in part to metabolic factors associated with exposure to carcinogenic …
been attributed in part to metabolic factors associated with exposure to carcinogenic …
Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans
R Ghotbi, M Christensen, HK Roh… - European journal of …, 2007 - Springer
Objectives To investigate the CYP1A2 genotype-phenotype relationship and to compare
CYP1A2 genetic polymorphisms and enzyme activity in terms of the effect of smoking and …
CYP1A2 genetic polymorphisms and enzyme activity in terms of the effect of smoking and …
Pharmacokinetics, metabolism and interactions of acid pump inhibitors: focus on omeprazole, lansoprazole and pantoprazole
T Andersson - Clinical pharmacokinetics, 1996 - Springer
This review updates and evaluates the currently available information regarding the
pharmacokinetics, metabolism and interactions of the acid pump inhibitors omeprazole …
pharmacokinetics, metabolism and interactions of the acid pump inhibitors omeprazole …
Interindividual variability in inhibition and induction of cytochrome P450 enzymes
JH Lin, AYH Lu - Annual review of pharmacology and toxicology, 2001 - annualreviews.org
Drug interactions have always been a major concern in medicine for clinicians and patients.
Inhibition and induction of cytochrome P450 (CYP) enzymes are probably the most common …
Inhibition and induction of cytochrome P450 (CYP) enzymes are probably the most common …
Dietary effects on drug metabolism and transport
RZ Harris, GR Jang, S Tsunoda - Clinical pharmacokinetics, 2003 - Springer
Metabolic food-drug interactions occur when the consumption of a particular food modulates
the activity of a drug-metabolising enzyme system, resulting in an alteration of the …
the activity of a drug-metabolising enzyme system, resulting in an alteration of the …
Role of Human Microsomal and Human Complementary DNA-expressed Cytochromes P4501A2 and P4503A4 in the Bioactivation of Aflatoxin B1
EP Gallagher, LC Wienkers, PL Stapleton, KL Kunze… - Cancer research, 1994 - AACR
The metabolism of the carcinogenic mycotoxin aflatoxin B1 (AFB1) was examined in
microsomes derived from human lymphoblastoid cell lines expressing transfected CYP1A2 …
microsomes derived from human lymphoblastoid cell lines expressing transfected CYP1A2 …
Influence of food on the bioavailability of drugs
A Melander - Clinical pharmacokinetics, 1978 - Springer
Food intake exerts a complex influence on the bioavailability of drugs. It may interfere not
only with tablet disintegration, drug dissolution and drug transit through the gastrointestinal …
only with tablet disintegration, drug dissolution and drug transit through the gastrointestinal …